Novavax seeks WHO Approval

I’ve read there are many vaccine hesitant people avoiding the current vaccines because the viral vector based ones like J&J and Astrazeneca interact with your DNA and the mRNA vaccines are new technology that we don’t truly know what the long term implications will be, and they are fearful of both. I’ve had one of each and appear to be fine, but that is what these people say.

Novavax is seeking approval with the World Health Organization for their protein based vaccine, which is more like a traditional vaccine, with over a 90% effectiveness rating. This vaccine may help close the gap and get us closer to herd immunity because those who are hesitant about the current vaccine technology now have an option based on older proven vaccine technology…

Here is an older article from the Atlantic about the Novavax vaccine…

In this context, the success of the Novavax vaccine should be A1 news. The recent results confirm that it has roughly the same efficacy as the two authorized mRNA vaccines, with the added benefit of being based on an older, more familiar science. The protein-subunit approach used by Novavax was first implemented for the hepatitis B vaccine, which has been used in the U.S.since 1986. The pertussis vaccine, which is required for almost all children in U.S. public schools, is also made this way. Some of those people who have been wary of getting the mRNA vaccines may find Novavax more appealing.

This topic was automatically closed 14 days after the last reply. New replies are no longer allowed.